ArticleVaccine2022

Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 years.

Patricia C Lloyd et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.